Studies

ID Name Stage Status
AH 10/04   1x BEP vs. 2x BEP for patients with high risk stage I nonseminoma stage I
 active
CRAD001CDE21T   Everolimus for patients with relapsed/refractory germ cell tumors (RADIT) relapse good prognosis
relapse poor prognosis
late relapse
 active
    Registry for the treatment of germ cell cancer brain metastasis various active
    Registry for the salvage treatment of relapsed/refractory germ cell cancer relapse good prognosis
relapse poor prognosis
late relapse
 active
    Gemcitabine/oxaliplatin/paclitaxel for relapsed/refractory germ cell tumors (GOP) relapse poor prognosis
 closed
    High-dose chemotherapy PEI ± Darbepoetin metastatic poor prognosis
 closed
AH 09/03   BEP ± darbepoetin metastatic good prognosis
metastatic intermediate prognosis
 closed
    Adjuvant etoposide after high-dose chemotherapy various closed
AH 05/97   Radiotherapy for testicular intraepithelial neoplasia (TIN) TIN
 closed
AH 04/95   Radiotherapy vs. carboplatin for stage I seminoma seminoma stage I
 closed
CUOG-TE 05   Sunitinin for relapsed/refractory germ cell cancer (SUITE) relapse poor prognosis
 closed
EORTC 30974   HD-PEI vs. PEB in poor prognosis patients metastatic poor prognosis
 closed
    Evaluation of late toxicities after high-dose chemotherapy various closed
EORTC 30983   Taxol-BEP vs. BEP for patients with intermediate prognosis metastatic intermediate prognosis
 closed
AH 08/02   Correlation between height and risk for testicular cancer various closed